{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-035767","form_type":"8-K","ticker":"HROW","cik":"0001360214","company_name":"HARROW, INC.","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.321188+00:00","generated_at":"2026-06-21T03:12:34.037771+00:00","sec_items":["1.01","7.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Harrow Health secures $125M financing package (notes, equity, loan) to fund acquisition","bullets":["Common stock offering: 2,376,426 shares at $10.52 for gross proceeds of $25M, closed Dec 16.","Senior notes offering: $35M principal of 11.875% notes due 2027, priced Dec 16, closing expected Dec 20.","B. Riley affiliate committed $65M secured loan at 10.875% fixed interest rate.","Management and directors purchased $950,000 of the senior notes.","Proceeds, along with sale of non-ophthalmology assets, to fund recently announced acquisition and general purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-035767","json":"https://secwatch.observer/filing/0001493152-22-035767.json","markdown":"https://secwatch.observer/filing/0001493152-22-035767.md","text":"https://secwatch.observer/filing/0001493152-22-035767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/0001493152-22-035767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:12:34.037771+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b281bfe06c1ec48b17da8fd1dc730932d6a5b51","claim":"HARROW, INC. entered into Common Stock Underwriting Agreement with B. Riley Securities, Inc. valued at gross proceeds of $25,000,002 (effective 2022-12-13).","evidence_excerpt":"On December 13, 2022, Harrow Health, Inc. (the “Company”) entered into an underwriting agreement (the “ Common Stock Underwriting Agreement ”) with B. Riley Securities, Inc. (the “ Common Stock Underwriter ”) related to a registered direct offering of shares of the Company’s common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/0001493152-22-035767-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"B. Riley Securities, Inc."},{"label":"Value","value":"gross proceeds of $25,000,002"},{"label":"Effective","value":"2022-12-13"}],"fact_type":"material_agreement"},{"claim_id":"88cc807ce3481c97219e3b2ae9e4d816db7e1f20","claim":"HARROW, INC. entered into Notes Underwriting Agreement with B. Riley Securities, Inc., as representative of the several underwriters named therein valued at $35,000,000 aggregate principal amount of 11.875% Senior Notes due 2027 (effective 2022-12-15).","evidence_excerpt":"On December 15, 2022, the Company entered into an underwriting agreement (the “ Notes Underwriting Agreement ”) with B. Riley Securities, Inc., as representative of the several underwriters named therein (the “ Notes Underwriters ”), pursuant to which the Company agreed to sell to the Notes Underwriters $35,000,000 aggregate principal amount of 11.875% Senior Notes due 2027","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/0001493152-22-035767-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"B. Riley Securities, Inc., as representative of the several underwriters named therein"},{"label":"Value","value":"$35,000,000 aggregate principal amount of 11.875% Senior Notes due 2027"},{"label":"Effective","value":"2022-12-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}